HCB-20575-46516 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-03
Dose 1 — Moderna
2021-03-03
Dose 2 — Moderna
2021-12-10
Dose 3 — Moderna
2021-12-12
Registered in v-safe
2021-12-12
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-13
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-14
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Itching · Fatigue or tiredness

Adult check-in
2021-12-15
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Itching · None

Adult check-in
2021-12-17
Health check-in — day 7, dose 3
Feeling: Good · Diarrhea, Abdominal pain

Adult check-in
2021-12-24
Survey response — day 14, dose 3
MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activities

Free text: Terrible migraines

MedDRA releases: 2024-11 · check-in free text available
2021-12-31
Survey response — day 21, dose 3
MedDRA: Fatigue — Feeling: Fair

Free text: Fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-01-07
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2022-01-20
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-21
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-12
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-06-10
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2022-12-10
Survey response — 12 months, dose 3
MedDRA: Blindness, Dry eye, Exercise tolerance decreased, Eye disorder, Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Eye issues vision loss and severe dry eyes plus severe fatigue with exercise intolerance

MedDRA releases: 2024-11 · check-in free text available
2022-12-10
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-12-12
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-03	Moderna	No
2	2021-03-03	Moderna	No
3	2021-12-10	Moderna	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — day 14, dose 3

2021-12-24

Symptoms: Terrible migraines

Release 10 — day 21, dose 3

2021-12-31

Symptoms: Fatigue

Release 12 — 12 months, dose 3

2022-12-10

Symptoms: Eye issues vision loss and severe dry eyes plus severe fatigue with exercise intolerance

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Blindness	·	·	✓
SD	Dry eye	·	·	✓
SD	Exercise tolerance decreased	·	·	✓
SD	Eye disorder	·	·	✓
SD	Fatigue	·	·	✓
SD	Migraine	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release